Graft versus host disease (GvHD) is a complication from stem cell transplants where the patient recognises the cells as ...

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

The Otis Redding Center for the Arts (ORCA) is set to celebrate its public grand opening on Saturday, March 22, 2025. The ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Hesai Group (NASDAQ: HSAI) shares traded lower on Tuesday after short seller Blue Orca Capital released a report accusing the company of misleading investors.

A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...

Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

At least three orca whales were spotted swimming through Bellingham Bay on Tuesday. Bellingham resident Nate Wallace captured ...

Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...

Spoilers ahead for Doctor Odyssey Episode 10, “Shark Attack! Part 2: Orca!”** Doctor Odyssey Episode 9 (“Shark Attack!”) left ...

Transit ridership in the Puget Sound region jumped in 2024, officials respond to new reports as Amazon, World Cup, and ...